{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:25:06Z","timestamp":1791397506478,"version":"4.3.3"},"reference-count":71,"publisher":"Elsevier BV","issue":"52","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.vaccine.2012.10.015","type":"journal-article","created":{"date-parts":[[2012,10,19]],"date-time":"2012-10-19T20:39:42Z","timestamp":1350679182000},"page":"7447-7454","source":"Crossref","is-referenced-by-count":74,"title":["Rabies virus vaccines: Is there a need for a pan-lyssavirus vaccine?"],"prefix":"10.1016","volume":"30","author":[{"given":"Jennifer S.","family":"Evans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel L.","family":"Horton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Easton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony R.","family":"Fooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley C.","family":"Banyard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2012.10.015_bib0005","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1586\/14760584.3.4.333","article-title":"The challenge of new and emerging lyssaviruses","volume":"3","author":"Fooks","year":"2004","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2012.10.015_bib0010","first-page":"95","article-title":"Can rabies be eradicated?","volume":"131","author":"Rupprecht","year":"2008","journal-title":"Dev Biol (Basel)"},{"issue":"4","key":"10.1016\/j.vaccine.2012.10.015_bib0015","first-page":"263","article-title":"The rabies virus genome: an overview","volume":"60","author":"Tordo","year":"1993","journal-title":"Onderstepoort J Vet Res"},{"issue":"2","key":"10.1016\/j.vaccine.2012.10.015_bib0020","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.virusres.2006.01.014","article-title":"A highly attenuated rabies virus HEP-Flury strain reverts to virulent by single amino acid substitution to arginine at position 333 in glycoprotein","volume":"119","author":"Takayama-Ito","year":"2006","journal-title":"Virus Res"},{"issue":"5","key":"10.1016\/j.vaccine.2012.10.015_bib0025","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1128\/JVI.02327-07","article-title":"The glycoprotein and the matrix protein of rabies virus affect pathogenicity by regulating viral replication and facilitating cell-to-cell spread","volume":"82","author":"Pulmanausahakul","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2012.10.015_bib0030","series-title":"Virus taxonomy, VIIIth report of the ICTV","first-page":"623","article-title":"Rhabdoviridae","author":"Tordo","year":"2004"},{"issue":"5","key":"10.1016\/j.vaccine.2012.10.015_bib0035","first-page":"360","article-title":"Re-evaluating the burden of rabies in Africa and Asia","volume":"83","author":"Knobel","year":"2005","journal-title":"Bull World Health Organ"},{"issue":"11","key":"10.1016\/j.vaccine.2012.10.015_bib0040","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2807\/esm.10.11.00574-en","article-title":"Rabies remains a \u2018neglected disease\u2019","volume":"10","author":"Fooks","year":"2005","journal-title":"Euro Surveill"},{"issue":"1","key":"10.1016\/j.vaccine.2012.10.015_bib0045","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3201\/eid1301.060810","article-title":"Rabies encephalitis in malaria-endemic area, Malawi Africa","volume":"13","author":"Mallewa","year":"2007","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2012.10.015_bib0050","doi-asserted-by":"crossref","first-page":"e626","DOI":"10.1371\/journal.pntd.0000626","article-title":"The feasibility of canine rabies elimination in Africa: dispelling doubts with data","volume":"4","author":"Lembo","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2012.10.015_bib0055","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S1473-3099(11)70340-1","article-title":"Passive immunity in the prevention of rabies","volume":"12","author":"Both","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2012.10.015_bib0060","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1086\/592969","article-title":"A reliable diagnosis of human rabies based on analysis of skin biopsy specimens","volume":"47","author":"Dacheux","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2012.10.015_bib0065","series-title":"Vaccines for biodefense and emerging and neglected diseases","first-page":"605","article-title":"Rabies","author":"Fooks","year":"2009"},{"issue":"3","key":"10.1016\/j.vaccine.2012.10.015_bib0070","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3201\/eid1703.100894","article-title":"Phylogeny of European bat Lyssavirus 1 in Eptesicus isabellinus bats, Spain","volume":"17","author":"Vazquez Moron","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2012.10.015_bib0075","series-title":"Research advances in rabies","first-page":"239","article-title":"Bats and lyssaviruses","author":"Banyard","year":"2011"},{"issue":"2","key":"10.1016\/j.vaccine.2012.10.015_bib0080","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1439-0450.2003.00725.x","article-title":"Spill-over of European bat lyssavirus type 1 into a stone marten (Martes foina) in Germany","volume":"51","author":"Muller","year":"2004","journal-title":"J Vet Med B Infect Dis Vet Public Health"},{"issue":"2\u20133","key":"10.1016\/j.vaccine.2012.10.015_bib0085","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jcpa.2005.10.005","article-title":"Natural and experimental infection of sheep with European bat lyssavirus type-1 of Danish bat origin","volume":"134","author":"Tjornehoj","year":"2006","journal-title":"J Comp Pathol"},{"issue":"2","key":"10.1016\/j.vaccine.2012.10.015_bib0090","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3201\/eid1502.080637","article-title":"European bat Lyssavirus transmission among cats, Europe","volume":"15","author":"Dacheux","year":"2009","journal-title":"Emerg Infect Dis"},{"issue":"8477","key":"10.1016\/j.vaccine.2012.10.015_bib0095","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0140-6736(86)92336-6","article-title":"Human rabies of bat origin in Europe","volume":"1","author":"Lumio","year":"1986","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2012.10.015_bib0100","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/jmv.10481","article-title":"Case report: isolation of a European bat lyssavirus type 2a from a fatal human case of rabies encephalitis","volume":"71","author":"Fooks","year":"2003","journal-title":"J Med Virol"},{"issue":"8","key":"10.1016\/j.vaccine.2012.10.015_bib0105","first-page":"1519","article-title":"Novel lyssavirus in Natterer's bat, Germany","volume":"17","author":"Freuling","year":"2011","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2012.10.015_bib0110","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3201\/eid0603.000305","article-title":"Potential exposure to Australian bat lyssavirus, Queensland, 1996\u20131999","volume":"6","author":"McCall","year":"2000","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2012.10.015_bib0115","first-page":"504","article-title":"A human case of encephalitis due to a Lyssavirus recently identified in fruit bats","volume":"20","author":"Allworth","year":"1996","journal-title":"Commun Dis Intell"},{"issue":"12","key":"10.1016\/j.vaccine.2012.10.015_bib0120","doi-asserted-by":"crossref","first-page":"597","DOI":"10.5694\/j.1326-5377.2000.tb124126.x","article-title":"Australian bat lyssavirus infection: a second human case, with a long incubation period","volume":"172","author":"Hanna","year":"2000","journal-title":"Med J Aust"},{"issue":"12","key":"10.1016\/j.vaccine.2012.10.015_bib0125","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.3201\/eid0912.030374","article-title":"Novel lyssaviruses isolated from bats in Russia","volume":"9","author":"Botvinkin","year":"2003","journal-title":"Emerg Infect Dis"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2012.10.015_bib0130","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.virusres.2008.04.021","article-title":"Complete genomes of Aravan, Khujand, Irkut and West Caucasian bat viruses, with special attention to the polymerase gene and non-coding regions","volume":"136","author":"Kuzmin","year":"2008","journal-title":"Virus Res"},{"issue":"22","key":"10.1016\/j.vaccine.2012.10.015_bib0135","doi-asserted-by":"crossref","first-page":"11841","DOI":"10.1128\/JVI.01153-10","article-title":"Quantifying antigenic relationships among the Lyssaviruses","volume":"84","author":"Horton","year":"2010","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2012.10.015_bib0140","first-page":"68","article-title":"Isolation and genetic characterisation of a new lyssavirus strain in the Primorskiy kray","volume":"16","author":"Belikov","year":"2009","journal-title":"East Siberian J Infect Pathol"},{"issue":"6","key":"10.1016\/j.vaccine.2012.10.015_bib0145","doi-asserted-by":"crossref","first-page":"926","DOI":"10.3201\/eid1406.071421","article-title":"Antibodies against Lagos bat virus in megachiroptera from West Africa","volume":"14","author":"Hayman","year":"2008","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2012.10.015_bib0150","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.virusres.2008.02.001","article-title":"Phylogeny of Lagos bat virus: challenges for lyssavirus taxonomy","volume":"135","author":"Markotter","year":"2008","journal-title":"Virus Res"},{"issue":"2","key":"10.1016\/j.vaccine.2012.10.015_bib0155","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.virusres.2010.01.018","article-title":"Shimoni bat virus, a new representative of the Lyssavirus genus","volume":"149","author":"Kuzmin","year":"2010","journal-title":"Virus Res"},{"issue":"1","key":"10.1016\/j.vaccine.2012.10.015_bib0160","first-page":"93","article-title":"Isolation of a rabies related virus from the cerebrospinal fluid of a child with \u2018aseptic meningitis\u2019","volume":"3","author":"Familusi","year":"1972","journal-title":"Afr J Med Sci"},{"issue":"4","key":"10.1016\/j.vaccine.2012.10.015_bib0165","doi-asserted-by":"crossref","first-page":"664","DOI":"10.3201\/eid1804.111553","article-title":"Ikoma lyssavirus, highly divergent novel lyssavirus in an African civet","volume":"18","author":"Marston","year":"2012","journal-title":"Emerg Infect Dis"},{"issue":"18","key":"10.1016\/j.vaccine.2012.10.015_bib0170","doi-asserted-by":"crossref","first-page":"10242","DOI":"10.1128\/JVI.01628-12","article-title":"Complete genomic sequence of Ikoma Lyssavirus","volume":"86","author":"Marston","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2012.10.015_bib0175","first-page":"73","article-title":"Laboratory techniques in rabies: the fluorescent antibody test, Monograph Series","volume":"23","author":"Dean","year":"1973","journal-title":"World Health Organisation"},{"key":"10.1016\/j.vaccine.2012.10.015_bib0180","unstructured":"International Committee on Taxonomy of Viruses. Official Taxonomy: Updates since the 8th Report; 2009. Available from: http:\/\/www.talkictvonlineorg\/files\/proposals\/taxonomy_proposals_vertebrate1\/m\/vert04\/4068aspx [cited 27.07.12]."},{"key":"10.1016\/j.vaccine.2012.10.015_bib0185","series-title":"Rabies","first-page":"341","article-title":"Molecular epidemiology","author":"Nadin-Davis","year":"2007"},{"issue":"Pt 4","key":"10.1016\/j.vaccine.2012.10.015_bib0190","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1099\/vir.0.82692-0","article-title":"Comparative analysis of the full genome sequence of European bat lyssavirus type 1 and type 2 with other lyssaviruses and evidence for a conserved transcription termination and polyadenylation motif in the G-L 3\u2019 non-translated region","volume":"88","author":"Marston","year":"2007","journal-title":"J Gen Virol"},{"issue":"5682","key":"10.1016\/j.vaccine.2012.10.015_bib0195","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1126\/science.1097211","article-title":"Mapping the antigenic and genetic evolution of influenza virus","volume":"305","author":"Smith","year":"2004","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.vaccine.2012.10.015_bib0200","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1128\/JVI.75.7.3268-3276.2001","article-title":"Evidence of two Lyssavirus phylogroups with distinct pathogenicity and immunogenicity","volume":"75","author":"Badrane","year":"2001","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2012.10.015_bib0205","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.virusres.2005.03.009","article-title":"Efficacy of rabies biologics against new lyssaviruses from Eurasia","volume":"111","author":"Hanlon","year":"2005","journal-title":"Virus Res"},{"issue":"6","key":"10.1016\/j.vaccine.2012.10.015_bib0210","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0264-410X(88)90107-7","article-title":"Efficacy of rabies vaccines against Duvenhage virus isolated from European house bats (Eptesicus serotinus), classic rabies and rabies-related viruses","volume":"6","author":"Fekadu","year":"1988","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2012.10.015_bib0215","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/0042-6822(92)90465-2","article-title":"Rabies virus glycoprotein is a trimer","volume":"187","author":"Gaudin","year":"1992","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.vaccine.2012.10.015_bib0220","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1099\/0022-1317-64-4-843","article-title":"Antigenic sites on the CVS rabies virus glycoprotein: analysis with monoclonal F antibodies","volume":"64","author":"Lafon","year":"1983","journal-title":"J Gen Virol"},{"issue":"8","key":"10.1016\/j.vaccine.2012.10.015_bib0225","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1128\/JVI.65.8.4198-4203.1991","article-title":"Antigenicity of rabies virus glycoprotein","volume":"65","author":"Benmansour","year":"1991","journal-title":"J Virol"},{"issue":"32","key":"10.1016\/j.vaccine.2012.10.015_bib0230","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1016\/j.vaccine.2005.03.037","article-title":"Rabies human diploid cell vaccine elicits cross-neutralising and cross-protecting immune responses against European and Australian bat lyssaviruses","volume":"23","author":"Brookes","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.10.015_bib0235","series-title":"Rabies","first-page":"177","article-title":"Rabies-related viruses","author":"King","year":"1988"},{"key":"10.1016\/j.vaccine.2012.10.015_bib0240","first-page":"317","article-title":"Epidemiology and pathogenicity of African bat lyssaviruses","volume":"131","author":"Markotter","year":"2008","journal-title":"Dev Biol (Basel)"},{"key":"10.1016\/j.vaccine.2012.10.015_bib0245","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2174\/187152611795768079","article-title":"Human rabies encephalitis prevention and treatment: progress since Pasteur's discovery","volume":"11","author":"Dacheux","year":"2011","journal-title":"Infect Disord Drug Targets"},{"issue":"9","key":"10.1016\/j.vaccine.2012.10.015_bib0250","doi-asserted-by":"crossref","first-page":"e530","DOI":"10.1371\/journal.pntd.0000530","article-title":"Emerging technologies for the detection of rabies virus: challenges and hopes in the 21st century","volume":"3","author":"Fooks","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2012.10.015_bib0255","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1128\/JVI.69.3.1444-1451.1995","article-title":"Mokola virus glycoprotein and chimeric proteins can replace rabies virus glycoprotein in the rescue of infectious defective rabies virus particles","volume":"69","author":"Mebatsion","year":"1995","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.vaccine.2012.10.015_bib0260","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1099\/0022-1317-80-9-2343","article-title":"Lyssavirus glycoproteins expressing immunologically potent foreign B cell and cytotoxic T lymphocyte epitopes as prototypes for multivalent vaccines","volume":"80","author":"Desmezieres","year":"1999","journal-title":"J Gen Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2012.10.015_bib0265","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1128\/JVI.73.1.225-233.1999","article-title":"Chimeric Lyssavirus glycoproteins with increased immunological potential","volume":"73","author":"Jallet","year":"1999","journal-title":"J Virol"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2012.10.015_bib0270","first-page":"219","article-title":"Chimeric rabies viruses for trans-species comparison of lyssavirus glycoprotein ectodomain functions in virus replication and pathogenesis","volume":"125","author":"Genz","year":"2012","journal-title":"Berl Munch Tierarztl Wochenschr"},{"issue":"7","key":"10.1016\/j.vaccine.2012.10.015_bib0275","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1128\/JVI.76.7.3374-3381.2002","article-title":"Overexpression of the rabies virus glycoprotein results in enhancement of apoptosis and antiviral immune response","volume":"76","author":"Faber","year":"2002","journal-title":"J Virol"},{"issue":"27","key":"10.1016\/j.vaccine.2012.10.015_bib0280","doi-asserted-by":"crossref","first-page":"11300","DOI":"10.1073\/pnas.0905640106","article-title":"Effective preexposure and postexposure prophylaxis of rabies with a highly attenuated recombinant rabies virus","volume":"106","author":"Faber","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.vaccine.2012.10.015_bib0285","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1017\/S0950268807008965","article-title":"Cross-protective and cross-reactive immune responses to recombinant vaccinia viruses expressing full-length lyssavirus glycoprotein genes","volume":"136","author":"Weyer","year":"2008","journal-title":"Epidemiol Infect"},{"issue":"4","key":"10.1016\/j.vaccine.2012.10.015_bib0290","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1586\/14760584.4.4.533","article-title":"Vaccines for lyssaviruses other than rabies","volume":"4","author":"Nel","year":"2005","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"10.1016\/j.vaccine.2012.10.015_bib0295","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1086\/514285","article-title":"Human infection due to Ebola virus, subtype Cote d\u2019Ivoire: clinical and biologic presentation","volume":"179","author":"Formenty","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2012.10.015_bib0300","unstructured":"Miller, J. Russian scientist dies in Ebola accident at former weapons lab. The New York Times 2005. Available from: www.nytimes.com\/2004\/05\/25\/world\/russian-scientist-dies-in-ebola-accident-at-former-weapons-lab.html [cited 27.07.12]."},{"key":"10.1016\/j.vaccine.2012.10.015_bib0305","unstructured":"Pettinger, A. Ebola researcher in Germany is isolated after needle puncture. ProMED mail 2009."},{"issue":"28","key":"10.1016\/j.vaccine.2012.10.015_bib0310","first-page":"767","article-title":"An unusual case of human rabies thought to be of chiropteran origin","volume":"45","author":"Meredith","year":"1971","journal-title":"S Afr Med J"},{"issue":"6","key":"10.1016\/j.vaccine.2012.10.015_bib0315","doi-asserted-by":"crossref","first-page":"959","DOI":"10.4269\/ajtmh.1972.21.959","article-title":"A fatal human infection with Mokola virus","volume":"21","author":"Familusi","year":"1972","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"10.1016\/j.vaccine.2012.10.015_bib0320","first-page":"542","article-title":"Rabies-related Yuli virus; identification with a panel of monoclonal antibodies","volume":"33","author":"Selimov","year":"1989","journal-title":"Acta Virol"},{"key":"10.1016\/j.vaccine.2012.10.015_bib0325","first-page":"5","article-title":"Human rabies case caused from a bat bite in Ukraine","volume":"29","author":"Botvinkin","year":"2005","journal-title":"Rabies Bull Europe"},{"issue":"11","key":"10.1016\/j.vaccine.2012.10.015_bib0330","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1017\/S0950268810000373","article-title":"First encounter of European bat Lyssavirus type 2 (EBLV-2) in a bat in Finland","volume":"138","author":"Jakava-Viljanen","year":"2010","journal-title":"Epidemiol Infect"},{"issue":"1","key":"10.1016\/j.vaccine.2012.10.015_bib0335","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1006\/viro.2002.1417","article-title":"Sequence analysis of an isolate from a fatal human infection of Australian bat Lyssavirus","volume":"297","author":"Warrilow","year":"2002","journal-title":"Virology"},{"issue":"12","key":"10.1016\/j.vaccine.2012.10.015_bib0340","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.3201\/eid1212.060764","article-title":"Fatal human infection with rabies-related Duvenhage virus, South Africa","volume":"12","author":"Paweska","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2012.10.015_bib0345","doi-asserted-by":"crossref","DOI":"10.2807\/ese.13.02.08007-en","article-title":"Fatal case of human rabies (Duvenhage virus) from a bat in Kenya: The Netherlands, December 2007","volume":"13","author":"van Thiel","year":"2008","journal-title":"Euro Surveill"},{"issue":"4","key":"10.1016\/j.vaccine.2012.10.015_bib0350","first-page":"5","article-title":"A fatal case of bat Lyssavirus infection in Primorye Territory of the Russian Far East","volume":"33","author":"Leonova","year":"2009","journal-title":"Rabies Bull Europe"},{"issue":"Pt 5","key":"10.1016\/j.vaccine.2012.10.015_bib0355","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1099\/0022-1317-80-5-1211","article-title":"Deduced structural model for animal rhabdovirus glycoproteins","volume":"80","author":"Walker","year":"1999","journal-title":"J Gen Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12014612?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12014612?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,30]],"date-time":"2022-01-30T11:34:13Z","timestamp":1643542453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12014612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":71,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0264410X12014612"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.10.015","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}